RxDoctor Payments Data

Megan Eaton, PA

Physician Assistant · Ballston Spa, NYNPI 1093440497

Payments from drug & device makers

$2,372in general payments, 2019–2025

Across 112 payments — averaging $21.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$499
  • AbbVie$472
  • Phathom Pharmaceuticals, Inc.$256
  • GSK$182
  • AstraZeneca$181
  • Lilly USA, LLC$132
  • plus $650 from 17 others

What the payments were for

  • Food & beverage$2,372100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,372 in reported general payments places this provider in the 85th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$11,109
Medicare patients
74
Services billed
137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban31$26,897
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$9,766
JardianceEmpagliflozin11$9,411
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$3,178
Atorvastatin Calcium147$1,631
Albuterol Sulfate HfaAlbuterol Sulfate32$1,311
Rosuvastatin Calcium64$946
Levothyroxine Sodium55$861
Gabapentin55$788
Losartan Potassium73$734
Lisinopril90$721
Omeprazole62$665
Metoprolol Succinate45$658
Pantoprazole Sodium32$635
Tamsulosin Hcl35$628

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$36$26,89731 claims
GSKTrelegy Ellipta$182$9,76612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Ballston Spa

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →